(See the Brief Report Maier et al, on pages 1378–82.)
Between 1975 and 2016, worldwide obesity rates have nearly tripled, with >1.9 billion adults aged ≥18 years (39%) considered overweight and 650 million (13%) considered obese [1]. An increasing percentage of children are also becoming obese. While increased weight is a recognized risk factor for several diseases, including diabetes, certain cancers, and cardiovascular diseases, this is not limited to noncommunicable diseases. Epidemiologic studies during the 2009 influenza pandemic highlighted, for the first time, that obesity was a high-risk factor for developing severe complications and dying from influenza virus infection [2, 3]. Although the mechanism(s) for increased disease severity in humans is unknown, animal models suggest that the increased disease severity may be multifactorial, involving issues such as viral spread and lung repair [4, 5] neutrophil extracellular trap formation [6], and modulation of the lung metabolome [7]. However, nothing was known about the impact of obesity on viral shedding and transmission. The studies reported by Maier et al in this issue of The Journal of Infectious Diseases provide the first evidence that obesity influences may influence the transmission of the virus, in addition to disease severity [8].
Using established household transmission and cohort studies in Managua, Nicaragua, Maier et al investigated the effects of obesity on the duration of viral shedding over 3 seasons (2015–2017). They demonstrated that symptomatic obese adults shed influenza A virus 42% longer than nonobese adults, as measured by reverse transcription polymerase chain reaction analysis. Although obesity was typically associated with more symptoms and disease severity, even asymptomatic or mildly ill obese adults shed influenza virus 104% longer than asymptomatic or mildly ill nonobese adults. This increased duration of viral shedding in obese individuals was specific to influenza A viruses; no association was found between obesity and duration of influenza B virus shedding [9]. Further, obesity did not appear to influence shedding duration in children aged 5–17 years. While further studies are needed to determine whether this is correlated with increased load and shedding of infectious virus, as well as the precise shedding cessation time, a recent study that sampled exhaled breath from influenza virus–infected college students found an association between obesity and quantity of virus shed [10], suggesting that increased shedding duration may be associated with higher viral loads. Regardless, these studies imply that obesity may play an important role in influenza virus transmission.
What does this mean for public health? It could mean that, with an increasing prevalence of obesity, the number of episodes of prolonged influenza virus shedding will increase, leading to increased opportunities to infect naive and high-risk populations. It is therefore even more important to develop effective strategies to prevent and control influenza, especially in the overweight and obese population, which could be challenging because of the poor vaccine responses in this population [11–15]. With increasing focus on the development of a universal influenza vaccine [16], improved protection from influenza is on the horizon. The question remains whether these approaches will not only protect this target population, but also reduce viral shedding duration. In addition, will these findings with influenza virus extend to other respiratory pathogens? This important question remains unanswered.
Notes
Financial support. This work was supported by the National Institute for Allergy and Infectious Diseases (grants R03 AI133527 and HHSN272201400006C) and the ALSAC.
Potential conflicts of interest. Author certifies no potential conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
- 1. World Health Organization. Obesity and overweight http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed June 12 2018.
- 2. Centers for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:749–52. [PubMed] [Google Scholar]
- 3. Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011; 8:e1001053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Easterbrook JD, Dunfee RL, Schwartzman LM, et al. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respir Viruses 2011; 5:418–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. O’Brien KB, Vogel P, Duan S, et al. Impaired wound healing predisposes obese mice to severe influenza virus infection. J Infect Dis 2012; 205:252–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Moorthy AN, Tan KB, Wang S, Narasaraju T, Chow VT. Effect of High-Fat Diet on the Formation of Pulmonary Neutrophil Extracellular Traps during Influenza Pneumonia in BALB/c Mice. Front Immunol 2016; 7:289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Milner JJ, Rebeles J, Dhungana S, et al. Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol 2015; 194:4846–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Maier HE, Lopez R, Sanchez N, et al. Obesity increases the duration of influenza A virus shedding in adults. J Infect Dis 2018; 218:1378–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775–85. [DOI] [PubMed] [Google Scholar]
- 10. Yan J, Grantham M, Pantelic J, et al. ; EMIT Consortium Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A 2018; 115:1081–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Green WD, Beck MA. Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc 2017; 14:406–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Karlsson EA, Meliopoulos VA, van de Velde NC, et al. A perfect storm: increased colonization and failure of vaccination leads to severe secondary bacterial infection in influenza virus-infected obese mice. MBio 2017; 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond) 2017; 41:1324–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Sheridan PA, Paich HA, Handy J, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012; 36:1072–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Karlsson EA, Hertz T, Johnson C, Mehle A, Krammer F, Schultz-Cherry S. Obesity outweighs protection conferred by adjuvanted influenza vaccination. MBio 2016; 7:e01144–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Erbelding EJ, Post D, Stemmy E, et al. A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases. J Infect Dis 2018; 218:347–54. [DOI] [PMC free article] [PubMed] [Google Scholar]